Nicolás Salinas-Parra1, Cristian Reyes-Martínez1, Minolfa C Prieto2, Alexis A Gonzalez3. 1. Instituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile. 2. Tulane University School of Medicine, New Orleans, Louisiana. 3. Instituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile. Electronic address: alexis.gonzalez@pucv.cl.
Abstract
BACKGROUND: Prostaglandin E2 (PGE2) regulates renin expression in renal juxtaglomerular cells. PGE2 acts through E-prostanoid (EP) receptors in the renal collecting duct (CD) to regulate sodium and water balance. CD cells express EP1 and EP4, which are linked to protein kinase C (PKC) and PKA downstream pathways, respectively. Previous studies showed that the presence of renin in the CD, and that of PKC and PKA pathways, activate its expression. The (pro)renin receptor (PRR) is also expressed in CD cells, and its activation enhances cyclooxygenase-2 (COX-2) through extracellular signal-regulated kinase (ERK). We hypothesized that PGE2 stimulates prorenin and renin synthesis leading to subsequent activation of PRR and upregulation of COX-2. METHODS: We used a mouse M-1 CD cell line that expresses EP1, EP3 and EP4 but not EP2. RESULTS: PGE2 (10-6M) treatment increased prorenin and renin protein levels at 4 and 8 hours. No differences were found at 12-hour after PGE2 treatment. Phospho-ERK was significantly augmented after 12 hours. COX-2 expression was decreased after 4 hours of PGE2 treatment, but increased after 12 hours. Interestingly, the full-length form of the PRR was upregulated only at 12 hours. PGE2-mediated phospho-ERK and COX-2 upregulation was suppressed by PRR silencing. CONCLUSIONS: Our results suggest that PGE2 induces biphasic regulation of COX-2 through renin-dependent PRR activation via EP1 and EP4 receptors. PRR-mediated increases in COX-2 expression may enhance PGE2 synthesis in CD cells serving as a buffer mechanism in conditions of activated renin-angiotensin system.
BACKGROUND:Prostaglandin E2 (PGE2) regulates renin expression in renal juxtaglomerular cells. PGE2 acts through E-prostanoid (EP) receptors in the renal collecting duct (CD) to regulate sodium and water balance. CD cells express EP1 and EP4, which are linked to protein kinase C (PKC) and PKA downstream pathways, respectively. Previous studies showed that the presence of renin in the CD, and that of PKC and PKA pathways, activate its expression. The (pro)renin receptor (PRR) is also expressed in CD cells, and its activation enhances cyclooxygenase-2 (COX-2) through extracellular signal-regulated kinase (ERK). We hypothesized that PGE2 stimulates prorenin and renin synthesis leading to subsequent activation of PRR and upregulation of COX-2. METHODS: We used a mouseM-1CD cell line that expresses EP1, EP3 and EP4 but not EP2. RESULTS:PGE2 (10-6M) treatment increased prorenin and renin protein levels at 4 and 8 hours. No differences were found at 12-hour after PGE2 treatment. Phospho-ERK was significantly augmented after 12 hours. COX-2 expression was decreased after 4 hours of PGE2 treatment, but increased after 12 hours. Interestingly, the full-length form of the PRR was upregulated only at 12 hours. PGE2-mediated phospho-ERK and COX-2 upregulation was suppressed by PRR silencing. CONCLUSIONS: Our results suggest that PGE2 induces biphasic regulation of COX-2 through renin-dependent PRR activation via EP1 and EP4 receptors. PRR-mediated increases in COX-2 expression may enhance PGE2 synthesis in CD cells serving as a buffer mechanism in conditions of activated renin-angiotensin system.
Authors: Andrew Advani; Darren J Kelly; Alison J Cox; Kathryn E White; Suzanne L Advani; Kerri Thai; Kim A Connelly; Darren Yuen; Judy Trogadis; Andrew M Herzenberg; Michael A Kuliszewski; Howard Leong-Poi; Richard E Gilbert Journal: Hypertension Date: 2009-06-22 Impact factor: 10.190
Authors: Alexis A Gonzalez; Torrance Green; Christina Luffman; Camille R T Bourgeois; L Gabriel Navar; Minolfa C Prieto Journal: Am J Physiol Renal Physiol Date: 2014-08-20
Authors: Liu Liu; Alexis A Gonzalez; Michael McCormack; Dale M Seth; Hiroyuki Kobori; L Gabriel Navar; Minolfa C Prieto Journal: Am J Physiol Renal Physiol Date: 2011-08-24
Authors: Alexis A Gonzalez; Lucienne S Lara; Christina Luffman; Dale M Seth; Minolfa C Prieto Journal: Hypertension Date: 2011-02-14 Impact factor: 10.190
Authors: Zhonghua Qi; Chuan-Ming Hao; Robert I Langenbach; Richard M Breyer; Reyadh Redha; Jason D Morrow; Matthew D Breyer Journal: J Clin Invest Date: 2002-07 Impact factor: 14.808
Authors: Mohammad Saleem; Conrad P Hodgkinson; Liang Xiao; Juan A Gimenez-Bastida; Megan L Rasmussen; Jason Foss; Alan J Payne; Maria Mirotsou; Vivian Gama; Victor J Dzau; Jose A Gomez Journal: Am J Physiol Renal Physiol Date: 2019-11-25
Authors: Anne D M Riquier-Brison; Arnold Sipos; Ágnes Prókai; Sarah L Vargas; Lldikó Toma; Elliott J Meer; Karie G Villanueva; Jennifer C M Chen; Georgina Gyarmati; Christopher Yih; Elaine Tang; Bahram Nadim; Sujith Pendekanti; Ingrid M Garrelds; Genevieve Nguyen; A H Jan Danser; János Peti-Peterdi Journal: Am J Physiol Renal Physiol Date: 2018-04-18
Authors: Hui Lin; Frank Geurts; Luise Hassler; Daniel Batlle; Katrina M Mirabito Colafella; Kate M Denton; Jia L Zhuo; Xiao C Li; Nirupama Ramkumar; Masahiro Koizumi; Taiji Matsusaka; Akira Nishiyama; Martin J Hoogduijn; Ewout J Hoorn; A H Jan Danser Journal: Pharmacol Rev Date: 2022-07 Impact factor: 18.923
Authors: Venkateswara R Gogulamudi; Danielle Y Arita; Camille R T Bourgeois; Justine Jorgensen; Jing He; William C Wimley; Ryosuke Satou; Alexis A Gonzalez; Minolfa C Prieto Journal: Sci Rep Date: 2021-07-05 Impact factor: 4.379